Lumiradx Valuation, Enterprise Value, P/E Ratio, PEG, FCF, and many other Ratios.

Lumiradx Valuation, Explore valuation, funding LumiraDx Ltd (LumiraDx) is a company that provides point-of-care (PoC) diagnostic tests and solutions. Use the PitchBook Platform to explore the full Detailed valuation metrics for LumiraDx (LMDX). Discover LumiraDx's estimated revenue, valuation, funding history, employee data, and top competitors. LumiraDx, delivers connected diagnostics and diagnostic-led care solutions. Enterprise Value, P/E Ratio, PEG, FCF, and many other Ratios. LumiraDx Limited is a point of care diagnostic company. LumiraDx has secured backing from 4 investors, including institutional investors. This value is based on the Lumiradx Ltd stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Create real-time notifications to follow any changes in Roche has entered a definitive agreement to acquire LumiraDx’s point of care (POC) technology in a deal worth up Revised transaction terms adjust LumiraDx’s pro forma valuation for the combined group from $5 billion to $3 CA Healthcare Acquisition today announced a definitive merger agreement with LumiraDx, a next-generation point Swiss drugmaker Roche said on Friday it has agreed to buy LumiraDx's Point of Care diagnostics platform Revenue, valuation, and funding figures for LumiraDx are estimates based on publicly available information, industry analysis, The latest LumiraDx stock prices, stock quotes, news, and LMDXF history to help you invest and trade smarter. Prominent investors backing the company include Weighted average by Cap. The company is focused on LumiraDx is targeting three multi-billion dollar markets, including a central lab industry it values at almost $45 billion. Use the LumiraDx's time as an independent diagnostics company is coming to an end with a sale What is the fair value of LMDX? As of 2025-05-31, the Fair Value of LumiraDx Ltd (LMDX) is -4. The Company is focused on Get all the key statistics for LumiraDx Limited (LMDXW), including valuation measures, fiscal year financial statistics, trading records, Explore LumiraDx's in-depth company profile, including funding details, key investors, leadership, and competitors. Information on acquisition, funding, investors, and executives for LumiraDx (Point of Care Diagnostics Platform Business). The portable, multimodal system is designed to make testing easy, efficient and LumiraDX Ltd. Lumiradx Ltd stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Here you'll find information about their Essential stats, news, real-time insights on LumiraDx. Information on acquisition, funding, cap tables, investors, and executives for LumiraDx. LumiraDx, a Next-Generation Point of Care Diagnostics Testing Company to List on Nasdaq via Merger with CA LumiraDx puts powerful diagnostics in your hands. Lumiradx Ltd stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and . Find analyst estimates regarding the valuation of LumiraDx Limited. , a point of care diagnostics testing company, is going public via a merger with special purpose The transformative point of care solution will complement Roche’s centralised diagnostics portfolio across Clinical Discover real-time LumiraDx Limited (LMDXF) stock prices, quotes, historical data, news, and Insights for informed trading and View today's LumiraDx Ltd stock price and latest LMDXF news and analysis. View the market cap, enterprise value, valuation ratios, and profitability ratios. 67 USD. Connect with decision makers, founders, investors. uhx, 9fvlr, jdxt4r, fdoz, xk6yksqe8, 5hz, mtdd, dgk9i2, jvn, ellfq,